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SUMMARY
Drugoverdosesingeneralareincreasingandoverdosesofcardiacmedicationsarealsoincreasing;
some areassociated with ahighmortality. Temporarycardiacpacinghas avaluable rolein cases
of hypotension related to dysrhythmia, or when it is necessary to provide overdrive pacing.
However, despite technically successful anduncomplicated pacemakerinsertion and restoration
of cardiac electrical activity, patients developing bradyarrhythmia and hypotension after an
overdose are in a high risk group.
INTRODUCTION
Deliberate drug overdose is a common
presentation at Accident and Emergency
departments throughout the country. In the year
1st April 1996 to 3rd March 1997, 807 cases of
deliberateoverdosewereadmittedtoAltnagelvin
Hospital; thisrepresents almost 12%ofallmedical
admissions at this hospital (6745 admissions,
including2190cardiology cases),comparedwith
321 cases in 1980, 290 in 1981 and 444 in 1982,
when they represented 14% of acute medical
admissions.' In the vast majority of cases, after
initial assessment and treatment, most are
medically well. However, a number can be in
dangerofeitheracuterespiratoryorcardiacarrest,
which may be fatal; artificial ventilation and
temporary cardiac pacing respectively may be
required.
METHODS
This is aretrospective review ofsix known cases
of drug overdose requiring temporary cardiac
pacing between November 1994 and February
1997. Datawerecollectedonage, sex,pastcardiac
and psychiatric history, haemodynamic signs,
electrocardiographic changes, therapeutic
interventionandfinaloutcomeinthesixpatients.
CASE HISTORIES
Case 1. A 46 year old woman was admitted
havingtakenanoverdoseof1200mgofflecainide
andanunknownquantityofsotalolatanunknown
time. She had a past history ofparoxysmal atrial
fibrillation with an exercise stress test mildly
positive for ischaemia and she had been taking
these drugs prophylactically for three and a half
years and nine months respectively. She had no
past history of psychiatric disease or of prior
overdose.
On admission to the Accident and Emergency
department shewasdrowsybutstillrousable; her
heart rate was 30 beats per minute and her blood
pressure (BP) 60/25 mmHg. Her ECG showed a
broad complex bradycardia. She was treated
initially with 3mg ofintravenous atropine given
as five boluses of 600 mcg. Although her heart
rate rose to 53 beats per minute, her BP became
unrecordable and she was transferred to the
cardiologyunitforemergencytemporarycardiac
pacing. During transit, she developed electro-
mechanical dissociation. She was intubated and
treatedwith3 mgofintravenous adrenalinegiven
as 1 mg boluses, along with cardiopulmonary
resuscitation and inotropic support with
intravenousdobutamine.Atemporarypacingwire
was inserted via the right supraclavicular
approach; the wire was placed in a satisfactory
position but there was failure to respond and the
patient died.
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Case 2. A 33 year old woman presented at
AccidentandEmergencyhavingtakenherfather's
diltiazem, atenolol, isosorbide mononitrate and
nifedipine. The of tablets and the time when
taken were notknown. She had apastpsychiatric
history of anorexia and severe depression
requiringformalpsychiatric admissions. Shehad
no history of deliberate self-harm but has since
been re-admitted with a second overdose.
She was very agitated on admission, heart rate
was 35 beats per minute, systolic blood pressure
60 mmHg and ECG showed a nodal bradycardia.
She was treated with an intravenous infusion of
Gelofusine, intravenous atropine 600 mcg given
three times, 10 mls of 10% calcium gluconate
intravenously, intravenous glucagon 3 mg in 20
mls of 5% dextrose over five minutes and an
intravenous infusion of dobutamine. As there
was little improvement in her haemodynamic
status a cardiac pacing wire was inserted. Blood
pressure after pacemaker insertion increased to
85/33 mmHg.
The dobutamine infusion rate was increased and
the blood pressure further improved to 90/50
mmHg that evening, and was 105/60 mmHg the
nextmorning. Shewaslaterseenbythepsychiatry
team who felt the diagnosis was of a borderline
personality disorder. The remainder of her stay
was uneventful and she was discharged.
Case 3. A 17 yearoldboy was transferred from
another hospital for temporary pacemaker
insertion. He had presented there at 12.30 am
having taken an overdose of digoxin 15 mg,
mefenamic acid 2000 mg and Tylex (two tablets)
at 10 pm the previous night. He had a history of
depression and had three previous admissions
following overdose in the past. Cardiac
monitoring showed him to be having episodes of
asystolelastingupto six seconds, andepisodesof
ventricular bigeminal rhythm. A digoxin level
taken at 5 am had shown alevel of 10.77 mcgper
litre (therapeutic range 0.8 to 2.0). His initial
heart rate was 89 beats per minute and blood
pressure 155/88 mmHg, both of which had been
maintained despite his arrythmias. He was
transferred toAltnagelvinhospital fortemporary
cardiac pacing.
On arrival he was awake and alert, heart rate was
74 beats per minute and blood pressure
137/82 mmHg. ECU showed sinus rhythm with
ST changes attributable to digoxin ("reverse
tick"). He was treated initially with 12 vials of
Digibind and later with a further 4 vials. In view
ofhisdocumentedperiodsofasystole, atemporary
pacing wire was inserted viathe right subclavian
vein without complication, and capture was
achieved. Temporary pacing was only required
for a short time after return to the Coronary Care
Unit as the patient remained in sinus rhythm
without pauses after further administration of
Digibind.
The serum digoxin level gradually decreased to
acceptable levels. No further periods ofasystole
were noted and he remained haemodynamically
stable andthe wire was removed. He was seenby
thepsychiatryteamwhofelttherewasnoevidence
of mental illness and that the overdose had been
an impetuous gesture.
Case 4. A 20 year old lady presented to the
AccidentandEmergencydepartmenthavingtaken
an overdose of20 tablets ofquinine sulphate 300
mg (total dose 6000 mg) two hours prior to her
arrival. She had no relevantpast medical history.
The medication belonged to a relative.
On arrival she was drowsy but rousable; she
complained of having hearing loss but initially
had no visual disturbance. Although her heart
rate was 108 beats perminute andblood pressure
115/60 mmHg, the ECG showed right axis
deviation and first degree heart block. Gastric
lavage was performed and she was also given
activated charcoal. Blood sent for analysis later
showed a quinine level of20.6 mg/l (toxic levels
>10.0mg/l) and apotassiumconcentration of2.6
mmol/l. Intravenous fluids containing potassium
supplementation were commenced. She com-
plained laterofhaving totalloss ofvision andher
pupils were found to be dilated and non-reactive.
Soon after admission she developed ventricular
tachycardia, but her blood pressure was well
maintained and she was treated with a bolus of
amiodarone 150 mg intravenously, followed by
aninfusionofamiodarone(900mgover24hours).
Forty minutes after admission she developed a
tonic-clonic seizure lasting 5 minutes which
resolved with the administration of 5 mg of
intravenous diazepam. Post-seizure monitoring
showed her to be in persistent ventricular
tachycardia with a good blood pressure (120/50
mmHg). She was treated with DC cardioversion,
requiring shocks of 1OOJ and then 200J before
sinus rhythm returned. It was felt that temporary
pacing was required as a prophylactic measure,
given the combination of first degree atrio-
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ventricular dissociation and ventricular
tachycardia. Temporarypacemakerinsertionwas
successfullyperformedviatherightfemoralvein
asthe subclavian andinternaljugularveins could
not be entered due to the patient's agitation.
Overdrive pacing was not required.
The remainder of her stay was unremarkable
from a cardiac viewpoint. Her heart rate and
blood pressure were well maintained and there
were no further episodes of ventricular
tachycardia. Herhearingreturnedtonormalquite
quickly and her vision made similar, but slower,
progress. She was seen by the psychiatry team
who did not find her to be mentally unwell, and
she was discharged.
Case 5. A 32yearoldman was admittedhaving
taken an overdose of 1200 mg of diltiazem, 900
mg of isosorbide mononitrate and possibly
bisoprolol while under the influence of alcohol
aboutthreehourspreviously. Hehadapasthistory
of ischaemic heart disease with an inferolateral
myocardial infarction and subsequent episodes
ofangina requiring hospital admission. He had a
prior diagnosis of depression, which was felt to
bereactive, andalsoofphobic anxiety,buthehad
not taken an overdose before. The medications
taken were for his own use.
He was drowsy on admission but awake; his
pulseratewas48beatsperminute,bloodpressure
40/10 mmHg and ECG showed a nodal
bradycardia. He was treated with gastric lavage,
charcoal, intravenous atropine 1200 mcg in two
equaldosesand 10mlsof 10% calciumgluconate
initially. Blood alcohol level was 198 mg%. The
heartrateimprovedto61 beatsperminuteandthe
blood pressure rose to 60/40mmHg. He was
commenced on intravenous infusions of
dobutamine and dopamine to provide inotropic
support.
The following morning his blood pressure had
risento78/44mmHgbutheremainedbradycardic
at 50 beats per minute. ECG continued to
demonstrate anodal bradycardia. Forthis reason
(nodalbradycardiawithhypotension)atemporary
cardiacpacingwire was successfully insertedvia
the left supraclavicular approach.
Blood pressure rose to 105/70 mmHg following
this procedure and he was gradually weaned off
both dopamine and dobutamine. Haemodynamic
stability was restored and the pacing wire was
removed. He was seen by the psychiatrists who
offered him admission to the local psychiatric
hospital but this was declined and he was
discharged.
Case 6. A 14 year old boy presented at the
Accident and Emergency department via
ambulancehavingtakenanoverdoseestimatedat
2800 mg of atenolol and 5400 mg of diltiazem
around ten hours prior to admission. The drugs
taken were not for his personal use and his past
medical history was totally unremarkable.
On admission he was drowsy but still able to
communicate coherently. His heart rate was 51
beats per minute, blood pressure 60/31 mmHg
and ECG showed a nodal bradycardia. Twenty
minutes later his heart rate dropped to 36 beats
per minute with an unrecordable blood pressure.
He was treated with intravenous atropine 3 mg
given in five boluses of600 mcg, 10 mls of 10%
calciumgluconate, 1 mgofintravenousglucagon,
intravenous Gelofusine and was commenced on
an intravenous infusion of dobutamine; it was
decided that temporary cardiac pacing was
necessary. Before transfer to the cardiology unit
he developed asystole which was treated with
cardiopulmonary resuscitation and intravenous
boluses of adrenaline; he was successfully
resuscitated and moved immediately to the
Cardiologyunitwhereatemporarycardiacpacing
wire was inserted via the left supraclavicular
approach without difficulty. He subsequently
developed electromechanical dissociation with a
satisfactory pacing rhythm on the monitorbuthe
hadnopalpablecardiacoutputandnoventricular
systole was seen on X-ray screening of the
mediastinum. He had been intubated and was
commenced on cardiopulmonary resuscitation
combined with intensive inotropic support with
highdoseadrenaline, noradrenaline, dobutamine
and Gelofusine. He alsoreceivedfurtherdoses of
calcium gluconate and glucagon. Although he
had a strong output with CPR, no spontaneous
cardiacoutputwasdetecteddespiteclearelectrical
activityonmonitor. Afteraperiodofresuscitation
whichlastedthreehoursintotalwithnodetectable
recovery, this was discontinued and he was
pronounced dead.
DISCUSSION
Although these data are retrospective and
uncontrolled, we feel that they are useful
indicators ofthe type ofrhythm disturbance that
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TABLE
Summary ofinformation in the six casespresented
Patient 1 Patient 2 Patient3 Patient 4 Patient 5 Patient6
Age 46 years 33 years 20 years 17 years 32 years 14 years
Sex Female Female Female Male Male Male
Cardiac Paroxysmal None None None Myocardial None
History atrial infarcation;
fibrillation; angina
mildly
positive
EST
Psychiatric None Anorexia, None Depression Depression; None
History Depression, Phobic
Personality anxiety
disorder
Prior None No, but one No Three known None None
Overdose since
Drugstaken Flecainide Diltiazem, Quinine Digoxin Diltiazem Atenolol
and dosage 1200 mg; Atenolol, sulphate 15 mg; 1200 mg; 2800 mg;
Sotalol Isosorbide 600 mg Mefenamic Isosorbide Diltiazem
(unknown mononitrate acid 2 g; momonitrate 5400 mg
dose) Nifedipine Tylex 2tabs 900 mg;
(doses ?Bisoprolol
unknown)
Time until Unknown Unknown 2 hours 2 hours, 3 hours 10 hours
presentation 30 mins
after taking
overdose
Heart rate 30 bpm 35 bpm 108 bpm 89 bpm 48 bpm 51 bpm
on admission
Blood 60/25 60 mmHg 115/60 155/88 40/10 mmHg 60/31 mmHg
pressure on mmHg systolic mmHg mmHg
admission
ECG Broad Nodal Right axis Episodes of Nodal Nodal
findings complex bradycardia deviation; asystole; bradycardia bradycardia
bradycardia first degree ventricular
heart block, bigeminy
ventricular
tachycardia
(later)
Indication Bradycardia Bradycardia Persistent Episodes of Bradycardia Bradycardia
for pacing with with ventricular asystole up with with
hypotension hypotension tachycardia to 6 secs hypotension hypotension
Blood 85/33 mmHg 132/71 97/55 mmHg 105/70
pressure mmHg mmHg
after pacing
Outcome Dead Alive Alive Alive Alive Dead
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may occur after overdose of cardiotoxic
medications. It is impossible to prove whether
pacing influences the outcome in these patients,
but it would be unethical and clinically
unacceptable to withhold temporary pacemaker
insertion in a patient with documented
bradydysrhythmia and hypotension; given the
negative chonotropic effects of all the drugs
ingested, temporary pacemaker insertion is a
rational therapy to adopt.
Although deliberate drug overdose is a common
reason for acute medical admission to hospital,
few suchcases requiretemporarycardiacpacing.
However,themortalityinthisgroupofpatients is
anindicatoroftheworryingprognosis inpatients
who require temporary cardiac pacing as a
consequence ofdrug-induced arrhythmias. Beta-
blockers and calcium channel blockers were the
drugs most commonly implicated. Calcium
channel blockers are increasingly prescribed for
hypertension, angina and arrhythmias and with
theirrise inpopularity there has been an increase
in the incidence of overdose of these drugs.2'3
Threeofthesixcasesdescribedinvolvedoverdose
of calcium channel blockers; all presented with
nodal bradycardia and hypotension which are
predictablefromtheirpharmacological actionon
the myocardium, vascular smooth muscle and
cardiac conducting system.4 Other clearly
documented side effects include sinus
bradycardia, accelerated atrioventricular node
conduction, secondandthirddegreeheartblock.'
Theidealemergencytreatmentofcalciumchannel
overdose has yet to be defined, but includes
calcium, glucagon, atropine, isoproterenol,
dopamine, dobutamine, adrenaline and
noradrenaline. The administration ofcalcium is
not always effective in treating overdoses of a
calcium channel blocker, but clinical
improvement has been demonstrated in most
instances.3
The use of cardiac pacing in calcium channel
blockeroverdosehasbeenmentionedinanumber
of sources with an overall positive response but
also acknowledgment that there may be a failure
tocapturesuccessfullyorwithnohaemodynamic
improvement, as in case 6.2,3'5
Beta adrenergic blocking agents are used in
angina, hypertension and as anti-arrhythmic
agents. The usual clinical manifestations ofbeta-
blocker overdose include bradycardia,
hypotension, low cardiac output, cardiac failure,
cardiogenic shock, bronchospasm, respiratory
failure, seizures and prolonged intraventricular
conduction.6
Thehaemodynamiccompromiseinducedbybeta-
blocker overdose usually responds to sympatho-
mimetics, parasympatholytics, glucagon,
phosphodiesterase inhibitors andcardiacpacing.
Glucagon in particular has been proposed as the
drug of choice due to its effect in increasing
levels of intracellular cyclic adenine mono-
phosphate (cAMP) independently of adrenergic
receptors. Cardiac pacing has been documented
in addition to glucagon as the treatment of first
choice for the management of beta-blocker
overdose.6
Flecainide is a class 1C anti-arrhythmic drug
indicated for the treatment of ventricular and
supraventricular dysrhythmias including Wolff-
Parkinson-White syndrome. Ingeneral, overdose
with this class of drug is associated with a high
mortality.7 It is felt that there is a correlation
between toxic levels in the blood and ECG
changes, in particular broadening of the QRS
complex. Other ECG changes reported include
prolongation of the PR interval, right bundle
branch block and giant inverted T waves.
Flecainide has a negative inotropic effect which
has been suggested as the cause ofthe profound
hypotension seen in many cases of overdose.
Survival after overdose is associated with
persistent ECG changes lasting more than 15
days. Thehypotensionhasbeenfoundtorespond
to intravenous dobutamine, dopamine and
isoprenaline.7
Quinine is usedforthe treatmentofnocturnal leg
cramps, malaria and myotonia. As itis an optical
isomer of quinidine, a class IA anti-arrhythmic
drug, quinine and quinidine have a number of
cardiotoxic effects including sinus tachycardia,
sinusbradycardia,wideningoftheQRScomplex,
prolongation of the PR and QT intervals,
atrioventricular blocks, broad complex tachy-
cardias, torsades de pointes and idioventricular
rhythms. Other effects include tinnitus, deafness
and visual disturbance.8
Standardpoisoningtreatmentandsupportivecare
are themainstay oftherapy in quininepoisoning.
Therapeuticinotropic supportandcardiacpacing
may be required.8
Digoxin is used in the treatment of atrial
fibrillation, paroxysmal supraventricular
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tachycardia, atrial flutter, and in cardiac failure.
Because of its effects on the myocardium,
sinoatrialandatrioventricularnodesviathevagus
nerve, digoxin in overdose will induce
arrhythmias including ventricular ectopic beats,
ventricular tachydysrhythmias, paroxysmal
supraventiicular tachycardia and heart block.
Death from digoxin intoxication usually results
from ventricular fibrillation, asystole, pump
failure or from mesenteric infarction.9
Digoxin overdose is treated by use of digoxin-
specific Fab antibody fragments as antidote.10
Indicationsforpacinginclude severebradycardia
(mostly secondary to atrioventricular block orto
sinoatrial block) and hyperkalaemia > 5 mmol/
L.9 There had been a suggestion that during
digoxin poisoning, the fibrillary threshold is
lowered and thus cardiac pacing may lead to
overdrive inhibition of spontaneous rhythms.
Although the failure rate with use of the
pacemaker was higher than with use of the Fab
antibody fragments, the difference was not
significant.9
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